NSP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Insperity Inc (NSP) is not a strong buy at the moment for a beginner investor with a long-term strategy. While there are some positive catalysts such as insider and hedge fund buying, the technical indicators suggest the stock is overbought, and the financial performance shows mixed results with negative net income and declining gross margins. Additionally, analyst sentiment is neutral to cautious, and no strong trading signals are present to justify immediate action.
The MACD is positive but contracting, indicating weakening momentum. RSI is at 80.521, signaling the stock is overbought. Moving averages are converging, suggesting indecision in the market. The stock is trading near its resistance level (R1: 32.367), which could limit further upside in the short term.
Hedge funds have increased buying by 247.65% in the last quarter, and insiders have increased buying by 4726.40% in the last month. These indicate strong institutional and insider confidence in the stock.
The company has rescheduled its earnings call, which could signal uncertainty or potential negative news. Analysts have lowered price targets, citing concerns about healthcare costs and a stagnant small business hiring environment. Additionally, the stock's overbought RSI and lack of recent congress trading data reduce confidence in immediate upside.
In Q4 2025, revenue increased by 3.41% YoY, but net income remained negative at -$33 million, albeit improving by 266.67% YoY. EPS also improved but remains negative at -0.87. Gross margin dropped significantly by -25.25% YoY to 9.59, indicating cost pressures.
Analysts have mixed views: Baird and JPMorgan maintain neutral or underweight ratings with lower price targets, while Roth Capital maintains a buy rating but also lowered its price target. The sentiment reflects cautious optimism but significant uncertainty.
